Protection Against Potential Brain Injury During Competitive Football

Sponsor
Children's Hospital Medical Center, Cincinnati (Other)
Overall Status
Completed
CT.gov ID
NCT02696200
Collaborator
(none)
62
1
2
25
2.5

Study Details

Study Description

Brief Summary

Significant morbidity, mortality, and related costs are caused by traumatic brain injury (TBI). An externally-worn medical device that applies mild jugular compression according to the principle of the Queckenstedt Maneuver (the Device). Preliminary research suggests that the Device has the potential to reduce the likelihood of TBI. The currently developed collar has been approved for studies in humans and the results indicate safety for use during high demand and maximal exertion activities, This study will investigate the effectiveness of this device in high school athletes playing a collision sport such as football. The use of helmets during such a high-risk sport will allow for collision measurement devices to be embedded in the helmet and will not affect play or fit of equipment. Athletes participating in this study will be randomly assigned to one of two groups: 1) Device wearing during the season or 2) Non-device wearing during the season. The helmets of all participants will be outfitted with an accelerometer which will measure the magnitude of every impact to the head sustained by the athlete. Effectiveness of the device will be determined via differences in longitudinal brain imaging and functional testing following competitive football participation. A subset of athletes who report a diagnosed concussion will also receive additional brain neuroanatomical and neurophysiological testing within a week following the diagnosed concussive event. The purpose of the study is to monitor longitudinal changes in brain structure and function between the preseason and postseason, in a population of football playing athletes wearing the Device and compared to a similar population not wearing the device. Secondly, the purpose is to determine the protection of the device relative to amount and magnitude of sustained head impacts.

Condition or Disease Intervention/Treatment Phase
  • Device: Q Collar
N/A

Detailed Description

The Device has the promise of providing a novel mechanism for reducing or preventing the likelihood of TBI, and may be used in conjunction with other protective equipment. TBI is the leading cause of death in individuals under age 45. The cost of TBI in the U.S. is estimated at anywhere from $50 to $150 billion, annually. The January, 2008 New England Journal of Medicine reports, "Head and neck injuries, including severe brain trauma, have been reported in one quarter of service members who have been evacuated from Iraq and Afghanistan". The vast majority of these injuries have resulted from exposure to improvised explosive device (IED) blast waves. Head injuries, concussions and the resulting trauma have been in public discussion recently as the National Football League (NFL) deals with a lawsuit regarding head injuries by about one-third of living former NFL players.

According to NASA, "The oscillation of a fluid caused by an external force, called sloshing, occurs in moving vehicles containing liquid masses, such as trucks, etc." This oscillation occurs when a vessel is only partially filled. It is hypothesized that the brain faces similar slosh energy absorption during external force impartation. Slosh permits external energies to be absorbed by the contents of a partially filled vessel or container by means of inelastic collisions. Tissues of differing densities can decelerate at different rates creating shear and cavitation. If the collisions between objects or molecules are elastic, the transfer of energies to those objects diminishes, minimizing the energies imparted by slosh.

Woodpeckers, head ramming sheep and all mammals (including humans) have small, little known and misunderstood muscles in their necks called the omohyoid muscles. Highly G-tolerant creatures of the forest have utilized these muscles to gently restrict outflow of the internal jugular veins thereby "taking up" the excess compliance of the cranial space and ultimately protecting themselves from TBI like tiny "airbags" in a motor vehicle. Rat studies by have demonstrated that we can easily and safely facilitate this muscle's actions by a well-engineered gentle compression over those muscles.

The medical Queckenstedt Maneuver devised to detect spinal cord compression, gently places pressure over the external jugular veins to increase cerebral spinal volume and pressure. In this maneuver, the veins are compressed while a lumbar puncture monitors the intracranial pressure. "Normally, the pressure rise to the higher 'plateau' level occurs instantly upon jugular compression to fall again equally fast upon release of the compression". This incredibly simple principle can be employed to protect soldiers and athletes from TBI by safely, and reversibly, increasing intracranial volume and pressure. The neck collar device is made of Outer collar - hytrel (thermoplastic elastomer), Inner collar - TPSiV (thermoplastic elastomer), metal insert (stainless steel), and is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh.

Although the skull, blood, and brain are "almost incompressible," the vasculature tree of the cerebrum is quite reactive and compressible. As volume is added to the cranium, eventually the compensatory reserve volume is surpassed and the intracranial pressure increases slightly. Increasing cerebral blood volume by just 1-3% safely and reversibly reduces compliance of the cerebral vascular tree and diminishes absorption of slosh energies. Jugular compression increases cerebral blood volume almost instantaneously. As mentioned, this degree of increase has significantly mitigated slosh and TBI in laboratory animals and mimics the highly concussion resistant wild animals that are able to reflexively increase cerebral blood volume through natural jugular compression.

A landmark article, published in the Journal of Neurosurgery, used a standard acceleration-deceleration impact laboratory model of mild TBI. The study showed a successful and marked reduction of axonal injury following Internal Jugular Vein (IJV) compression as indicated by immunohistochemical staining of Amyloid Precursor Proteins (APP). It is argued that IJV compression reduces slosh-mediated brain injury by increasing intracranial blood volume and reducing the compliance and potential for brain movement within the confines of the skull. The potential for such technique to mitigate both linear and rotational brain injury in humans by "internal protection" represents the most novel approach to mitigating TBI.

The current project will be designed following a prospective longitudinal study design. All MRI scanning will be performed on a 3 Tesla Philips Achieva MRI scanner located in Imaging Research Center (IRC) in the Cincinnati Children's Hospital Research Foundation (CCHRF). Sedation will not be used for any of the test visits. The entire MRI series, including anatomical imaging, DTI, resting state fMRI, SWI, HARDI, ASL and BOLD will be completed in 65 minutes or less (see Table 1 for detailed specifications). All functional and neurocognitive testing will be performed at the Cincinnati Children's Hospital Human Performance Laboratory.

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Novel Protection Against Potential Brain Injury During Competitive Football Head Impacts
Study Start Date :
May 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Subjects Wearing the Q Collar

Subjects wearing the Q collar throughout the football season

Device: Q Collar
The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt.

No Intervention: Subjects Not Wearing the Q Collar

Control group of subjects not wearing the q collar

Outcome Measures

Primary Outcome Measures

  1. Determine Average Number of Hits Between Groups [5 months]

    monitor the differences in average number of hits between the group wearing the collar and the group not wearing the collar

  2. Number of Participants Undergoing EEG Assessment [5 months]

    determine the number of subjects in the collar group and the non collar group that underwent EEG assessment

  3. Change in Fractional Anisotropy (FA) [6 months]

    Change in fractional anisotropy (FA) from Pre to Post season

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal healthy volunteer

  • Able to provide written consent

  • Must be 14 years or older and a participant on varsity level high school football team

Exclusion Criteria:
  • Unable to provide written consent

  • History of neurological deficits, previous cerebral infarction, or severe head trauma as indicated through pre-season screening:

  • Medical contraindications to restriction of venous outflow via the internal jugular veins (known increased intracerebral pressure, metabolic acidosis or alkalosis)

  • Glaucoma (Narrow Angle or Normal Tension)

  • Hydrocephalus

  • Recent penetrating brain trauma (within 6 months)

  • Known carotid hypersensitivity

  • Known increased intracranial pressure

  • Central vein thrombosis

  • Any known airway obstruction

  • Any known seizure disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cincinanti Childrens Hospital Medical Center Cincinnati Ohio United States 45229

Sponsors and Collaborators

  • Children's Hospital Medical Center, Cincinnati

Investigators

  • Principal Investigator: Gregory D Myer, PhD, Children's Hospital Medical Center, Cincinnati

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT02696200
Other Study ID Numbers:
  • 2015-2205
First Posted:
Mar 2, 2016
Last Update Posted:
Dec 9, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Children's Hospital Medical Center, Cincinnati
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar
Period Title: Overall Study
STARTED 32 30
COMPLETED 32 30
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar Total
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar Total of all reporting groups
Overall Participants 32 30 62
Age (Count of Participants)
<=18 years
32
100%
30
100%
62
100%
Between 18 and 65 years
0
0%
0
0%
0
0%
>=65 years
0
0%
0
0%
0
0%
Sex: Female, Male (Count of Participants)
Female
0
0%
0
0%
0
0%
Male
32
100%
30
100%
62
100%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
United States
32
100%
30
100%
62
100%

Outcome Measures

1. Primary Outcome
Title Determine Average Number of Hits Between Groups
Description monitor the differences in average number of hits between the group wearing the collar and the group not wearing the collar
Time Frame 5 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar
Measure Participants 32 30
Avg # of hits >20g
896.43
(600.03)
795.40
(508.92)
Avg # of hits >50g
144.67
(106.55)
145.85
(109.98)
Avg # of hits >100g
14.38
(11.29)
18.3
(20.85)
Avg # of hits >150g
2.43
(3.11)
1.8
(2.04)
Avg # of hits >200g
0.43
(1.17)
0.30
(0.73)
2. Primary Outcome
Title Number of Participants Undergoing EEG Assessment
Description determine the number of subjects in the collar group and the non collar group that underwent EEG assessment
Time Frame 5 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar
Measure Participants 32 30
Count of Participants [Participants]
32
100%
30
100%
3. Primary Outcome
Title Change in Fractional Anisotropy (FA)
Description Change in fractional anisotropy (FA) from Pre to Post season
Time Frame 6 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar
Measure Participants 32 30
Mean (Standard Deviation) [percentage of change]
0.03
(1.24)
2.43
(1.01)

Adverse Events

Time Frame 6 months
Adverse Event Reporting Description
Arm/Group Title Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Arm/Group Description Subjects wearing the Q collar throughout the football season Q Collar: The device is fitted to the neck to provide a comfortable and precise jugular compression that potentially mitigates cerebral slosh. The device will be worn inside the collar of an athletic compression shirt. Control group of subjects not wearing the q collar
All Cause Mortality
Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/32 (0%) 0/30 (0%)
Serious Adverse Events
Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/32 (0%) 0/30 (0%)
Other (Not Including Serious) Adverse Events
Subjects Wearing the Q Collar Subjects Not Wearing the Q Collar
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/32 (0%) 0/30 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Kim Foss
Organization Cincinnati Childrens Hospital
Phone 513-636-5971
Email kim.foss@cchmc.org
Responsible Party:
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT02696200
Other Study ID Numbers:
  • 2015-2205
First Posted:
Mar 2, 2016
Last Update Posted:
Dec 9, 2020
Last Verified:
Nov 1, 2020